Organs-on-chips Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Liver-on-chip, Kidney-on-chip, Lung-on-chip, Heart-on-chip and Other Organs); Offerings (Product and Services); Application (Physiological Model Development, Drug Discovery and Toxicology Research); End User (Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes, Cosmetic Industry and Other End Users.), and Geography (North America, Europe, Asia Pacific, and South and Central America)

The Organs-on-chips Market is expected to register a CAGR of 37.5% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented based on Type (Liver-on-chip, Kidney-on-chip, Lung-on-chip, Heart-on-chip and Other Organs); Offerings (Product and Services); Application (Physiological Model Development, Drug Discovery and Toxicology Research); End User (Pharmaceuticals and Biotechnology Companies, Academic and Research Institutes, Cosmetic Industry and Other End Users.). The global analysis is further broken down at the regional level and major countries. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Organs-on-chips Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

• Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
• Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
• Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Organs-on-chips Market Segmentation

Type

• Liver-on-chip
• Kidney-on-chip
• Lung-on-chip
• Heart-on-chip and Other Organs

Offerings

• Product and Services

Application

• Physiological Model Development
• Drug Discovery and Toxicology Research

End-User

• Pharmaceuticals and Biotechnology Companies
• Academic and Research Institutes
• Cosmetic Industry

Organs-on-chips Market Growth Drivers

• Rising Demand for Drug Discovery & Development: Organs-on-chips provide a more physiologically relevant platform for drug screening and toxicity testing, reducing reliance on animal models and accelerating the drug development process.
• Increasing Prevalence of Chronic Diseases: The growing burden of chronic diseases like cancer, diabetes, and neurodegenerative disorders necessitates better disease modeling tools, which organs-on-chips can provide for personalized medicine approaches.
• Advancements in Microfabrication & Bioengineering: Technological advancements in microfluidics, biomaterials, and 3D cell culture techniques are enabling the creation of increasingly sophisticated and complex organ-on-chip models.

Organs-on-chips Market Future Trends

• Integration with Artificial Intelligence (AI) & Machine Learning (ML): AI/ML algorithms can analyze complex data generated by organs-on-chips, enabling predictive modeling, personalized medicine, and accelerated drug discovery.
• Development of Body-on-a-Chip Systems: Connecting multiple organ-on-chip models to create "body-on-a-chip" systems will allow for more comprehensive studies of systemic diseases and drug interactions.
• Patient-Derived Organ-on-Chips: Utilizing patient-specific cells to create personalized organ-on-chip models will enable precision medicine approaches and improve the prediction of individual responses to drugs.

Organs-on-chips Market Opportunities

• Personalized Medicine: Organs-on-chips can be used to develop personalized medicine strategies by creating patient-specific models for drug testing and disease modeling.
• Toxicology Testing: Replacing animal models with organs-on-chips for toxicity testing can reduce the use of animals in research and provide more human-relevant data.
• Disease Modeling: Organs-on-chips can be used to study the mechanisms of various diseases, leading to a better understanding of disease progression and the development of new therapies.

Organs-on-chips Market Regional Insights

The regional trends and factors influencing the Organs-on-chips Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Organs-on-chips Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Organs-on-chips Market Report Scope

Organs-on-chips Market Players Density: Understanding Its Impact on Business Dynamics

The Organs-on-chips Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Organs-on-chips Market are:

1. Organovo
2. Hepregen
3. Hurel Corporation
4. Nortis
5. TissUse

Disclaimer: The companies listed above are not ranked in any particular order.

Key Selling Points

• Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Organs-on-chips Market, providing a holistic landscape.
• Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
• Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
• Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Organs-on-chips Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

The List of Companies

1. Organovo
2. Hepregen
3. Hurel Corporation
4. Nortis
5. TissUse
6. Tara Biosystems
7. AxoSim
8. Emulate Inc.
9. CN Bio Innovations.
10. MIMETAS.
11. Netri
12. Allevi.
13. Tara Biosystems Inc.
14. Altis Biosystems
15. InSphero AG